Related Experiment Videos
Sinusitis in HIV: microbiology and therapy.
Ashish R Shah1, Jahmal A Hairston, Thomas A Tami
1Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati, 231 Albert Sabin Way, PO Box 670528, Cincinnati, OH 45267, USA.
Current Allergy and Asthma Reports
|October 12, 2005
Summary
Rhinosinusitis is common in people with HIV. Diagnosis and treatment can be challenging, but effective strategies exist based on available tools and CD4 counts.
Area of Science:
- Medical research
- Infectious diseases
- Immunology
Background:
- Rhinosinusitis is increasingly prevalent in the human immunodeficiency virus (HIV)-infected population.
- HIV infection is now a chronic condition, leading to more frequent comorbidities like rhinosinusitis.
- Diagnosing and treating rhinosinusitis in HIV patients presents unique challenges.
Purpose of the Study:
- To review diagnostic and therapeutic options for rhinosinusitis in HIV-infected individuals.
- To provide guidance on managing this common condition in a specific patient group.
Main Methods:
- Literature review of diagnostic tools for rhinosinusitis.
- Analysis of microbial identification based on CD4+ T-cell counts.
- Evaluation of effective management and treatment strategies.
Main Results:
- Adequate diagnostic tools for rhinosinusitis are available for HIV-infected patients.
- Microbial pathogens can often be predicted using CD4 count.
- Effective management and treatment protocols can be implemented.
Conclusions:
- Rhinosinusitis management in HIV-infected individuals is feasible.
- Understanding diagnostic and therapeutic options is crucial for effective patient care.
- CD4 count serves as a valuable indicator for anticipating microbial causes.